Teva announces launch of $2,000,000,000 (equivalent) offering of senior notes

Tel aviv, israel, may 19, 2025 (globe newswire) -- teva pharmaceutical industries ltd. (nyse and tase: teva) (“teva”) announced today its intention to issue $2,000,000,000 (equivalent) of senior notes through its special purpose finance subsidiaries. teva pharmaceutical finance netherlands ii b.v. (“teva finance ii”) intends to offer eur-denominated senior notes (the “euro notes”) and teva pharmaceutical finance netherlands iii b.v. (“teva finance iii”) and teva pharmaceutical finance netherlands iv b.v. (“teva finance iv” and, together with teva finance ii and teva finance iii, the “issuers”) intend to offer usd-denominated senior notes (the “usd notes” and, together with the euro notes, the “notes”).
TEVA Ratings Summary
TEVA Quant Ranking